Skip to main content

Table 1 Examples of specific cancer types linked to dysregulated activity of AP-1 family members. In brackets we have indicated whether evidence points to up- or down-regulation of the AP-1 family member

From: Selective antagonism of cJun for cancer therapy

AP-1 family member

Type of cancer

Up/down-regulation

References

cJun

Breast cancer

Upregulation

[12, 13]

Colorectal cancer

Upregulation

[14]

Fibrosarcoma

Upregulation

[15]

Glioma

Upregulation

[16]

Hodgkin lymphoma

Upregulation

[17]

Lung cancer

Upregulation

[18]

Myeloid leukaemia

Upregulation

[19]

Urothelial carcinoma of the bladder

Upregulation

[20]

JunB

Breast cancer

Upregulation

[21]

Cervical cancer

Upregulation

[22]

Colon cancer

Upregulation

[23]

Fibrosarcoma

Upregulation

[15]

Head and neck squamous cell carcinoma

Upregulation

[24]

Hodgkin lymphoma

Upregulation

[17]

Prostate cancer

Downregulation

[25]

JunD

Cervical cancer

Upregulation

[22]

Prostate cancer

Upregulation

[26, 27]

cFos

Breast cancer

Upregulation

[28]

Cervical cancer

Upregulation

[22]

Colon cancer

Upregulation

[23]

Gastric cancer

Downregulation

[29]

Head and neck squamous cell carcinoma

Upregulation

[30]

Ovarian cancer

Downregulation

[31]

Pancreatic cancer

Upregulation

[32]

Skin cancer

Upregulation

[33]

Tongue cancer

Upregulation

[34]

Urothelial carcinoma of the bladder

Upregulation

[20]

FosB

Breast cancer

Downregulation

[35]

Colon cancer

Downregulation

[23]

Gastric cancer

Downregulation

[36]

Non-small cell lung cancer

Downregulation

[37]

Ovarian cancer

Upregulation

[38]

Pancreatic cancer

Downregulation

[39]

Fra1

Breast cancer

Upregulation

[40]

Cervical cancer

Downregulation

[22]

Colon cancer

Upregulation

[41]

Liver cancer

Upregulation

[42]

Lung cancer

Upregulation

[43]

Skin and hand and neck squamous cell carcinoma

Upregulation

[44]

Fra2

Breast cancer

Upregulation

[45]

Non-small cell lung cancer

Upregulation

[46]

Tongue cancer

Upregulation

[34]